Physician profile
Emerald Ford
NPI 1447942123
$623.23
in general payments reported to CMS, 2019-2025
12 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $103 · 2024: $322 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $140.73 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Lilly USA, LLC | $127.57 | 2023-2024 | Mounjaro, Zepbound, Trulicity |
| Dexcom, INC. | $123.66 | 2023-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $55.29 | 2023-2024 | |
| Astrazeneca Pharmaceuticals Lp | $35.24 | 2024 | Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $32.00 | 2024 | |
| Vanda Pharmaceuticals INC. | $20.98 | 2024 | Fanapt |
| Novavax INC | $20.25 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.88 | 2024 | Ofev |
| Exact Sciences Corporation | $17.48 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $15.26 | 2024 | Gardasil, Gardasil 9, Capvaxive |
| Xeris Pharmaceuticals, INC. | $14.89 | 2023 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emerald Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.